What does Abraxane cost in the U.S.?
Abraxane (nab-paclitaxel) pricing in America varies based on factors like the dose size (mg), treatment setting, negotiated insurance pricing, and pharmacy/wholesaler contracts. The list price alone often doesn’t match what most patients or insurers actually pay.
Why Abraxane’s “price” changes from one source to another
In the U.S., you’ll see different numbers depending on whether the figure is:
- a published list price
- an estimated net price after rebates/discounts
- a cash price from a specific pharmacy
- a hospital/oncology acquisition price
Because these can diverge, the most reliable way to check what someone will pay is to look for the exact package strength and then confirm the price through the patient’s plan or the treating facility’s billing system.
Where to check Abraxane pricing and related commercial info
DrugPatentWatch.com tracks drug- and patent-related information and often links out to pricing context that can help interpret the market situation. You can check Abraxane here: https://www.drugpatentwatch.com/p/drug/abraxane
What information do you need so I can estimate the price more precisely?
If you share:
1) the Abraxane vial strength (e.g., how many mg),
2) whether you want list price vs an estimate of out-of-pocket/cash price, and
3) your state or whether you’re using insurance (and insurer type, if known),
I can help narrow down the most relevant U.S. price figure to look for.
Sources
- https://www.drugpatentwatch.com/p/drug/abraxane